Summary by Futu AI
Hua Ling Pharmaceutical-B (02552.HK) filed its latest Securities Changes Month Report with Hong Kong Trading and Settlement Limited on May 7, 2024, reporting the change in company shares for the year ended April 30, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH AT 2,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.001 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $2,000,000. In addition, under the Company's stock option plan, the number of stock options outstanding at the end of the month was 52,897,591, and no new shares were issued during the month. COMPANY SECRETARY YUAN WING-XIN CONFIRMED THAT ALL SECURITIES ISSUANCE HAD BEEN AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.